Decision Options, LLC |
|
Data 2 Decisions |
|
DoESO - Employee Stock Options Evaluator Software |
|
Excerpt from Financial Accounting Standards Board (FASB) “On March 31, 2004, the Financial Accounting Standards Board (FASB) issued a proposed Statement, Share-Based Payment, that addresses the accounting for share-based payment transactions in which an enterprise receives employee services in exchange for (a) equity instruments of the enterprise or (b) liabilities that are based on the fair value of the enterprise’s equity instruments or that may be settled by the issuance of such equity instruments. The proposed Statement would eliminate the ability to account for share-based compensation transactions using APB Opinion No. 25, Accounting for Stock Issued to Employees, and generally would require instead that such transactions be accounted for using a fair-value-based method.”
On April 1st, Decision Options released the first version of DoESO, a user friendly software based on Decision Options proprietary options valuation tool called DoOptima. DoESO is already in use at one of the largest companies in the world. The functionality of DoESO is extensive, allowing users to specify the term structure of risk free rate, volatility and dividends to any duration. Additionally, the early exercise profile can be specified as a function of the stock price movement. To learn more about DoESO and how it will help you both save time and be ready for the upcoming accounting change, please contact us. If you have assigned credentials, download the software at the following link www.decisionoptions.org/doeso/software |
|
Decision Options is a specialized consulting firm focused on helping senior executives make better investment and portfolio decisions. Decision Options also provides general purpose Real Option valuation and portfolio management software (patent pending) to companies in various industries. Services include valuation and pricing of entities (products, technologies, processes and IP), business due diligence and intermediation of R&D product licensing. Decision Options clients come mainly from high technology, pharmaceuticals, biotechnology, venture capital, manufacturing, diagnostic equipment and energy industries. Products include software for valuation and portfolio management of real assets (proprietary technology based on real options analysis), financial derivative pricing and equity research. Decision Options engagements take different modalities including executive training, specialized problem solving and software implementation. Most engagements are conducted on a fixed fee or success fee basis with defined outcomes.
Link to Bloomberg article describing Decision Options method http://quote.bloomberg.com/apps/news?pid=10000039&sid=aUDmtXMs.1X4&refer=columnist_berton
|
|
Decision Options, LLC 94 Anchorage Circle Groton, CT 06340 |
